Loading...

VERV VERVE THERAPEUTICS INC US FDA Inspections 8-K Filing

VRV

VRV

VERVE THERAPEUTICS INC

(VERV)

2024 8-K

Show Summary

Show Summary

Merger of Equals

Financial Statements

Clinical Trial Update

Financial Results

Financial Results

Financial Results Announcement

Board Expansion and New Dir...

Update on Advisory Vote on ...

Annual Meeting of Stockholders

Appointment of Chief Scient...

Financial Results Announcement

Clinical Trial Pause

Financial Results Announcement

Underwriting Agreement

Interim Data Presentation

Financial Results Announcement

FDA Clearance for Clinical ...

Financial Results Announcement

Annual Meeting Results

Research Collaboration Agre...

Financial Results Announcement

Financial Results Announcement

Bylaws Amendment

External Links:

Verve Therapeutics has paused enrollment in the Heart-1 clinical trial of VERVE-101 due to laboratory abnormalities, but has received clearance for the Heart-2 trial of VERVE-102.

AI Assistant

VERVE THERAPEUTICS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.